Pyxis Oncology Inc.

NASDAQ: PYXS · Real-Time Price · USD
1.21
0.08 (7.08%)
At close: Aug 15, 2025, 3:59 PM
1.21
0.00%
After-hours: Aug 15, 2025, 07:37 PM EDT

Pyxis Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
16.15M n/a n/a n/a
Cost of Revenue
475K 2M 1.84M 1.25M
Gross Profit
15.67M -2M -1.84M -1.25M
Operating Income
-89.46M -82.2M -123.48M -69.72M
Interest Income
7.04M 6.63M 2.76M 23K
Pretax Income
-79.5M -73.79M -120.72M -75.97M
Net Income
-77.33M -73.79M -117.95M -81.54M
Selling & General & Admin
25.42M 32.61M 37.35M 18.66M
Research & Development
58.75M 47.89M 86.13M 51.05M
Other Expenses
20.96M n/a n/a 181K
Operating Expenses
105.13M 82.2M 123.48M 69.72M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
105.61M 82.2M 123.48M 69.72M
Income Tax Expense
-2.16M n/a -2.76M 5.56M
Shares Outstanding (Basic)
58.45M 39.9M 33.03M 32.22M
Shares Outstanding (Diluted)
58.45M 39.9M 33.03M 32.22M
EPS (Basic)
-1.32 -1.85 -3.57 -2.53
EPS (Diluted)
-1.32 -1.85 -3.57 -2.53
EBITDA
-65.51M -78.49M -122.77M -69.07M
EBIT
-68.5M -80.42M -123.48M -69.72M
Depreciation & Amortization
2.98M 2M 1.84M 1.25M